[1
]
From the Division of Cardiovascular Diseases, Cardiovascular Research Institute, and
the Midwest Stem Cell Therapy Center, University of Kansas Medical Center, Kansas
City (M.R.A., A.S., Z.I.S., B.D.); Heart and Vascular Specialists of Oklahoma, Oklahoma
City (V.J.); Division of Cardiology, University of Kentucky, Lexington (A.A.-L.);
and Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology,
Jagiellonian University, Krakow, Poland (E.K.Z.-S).
[2
]
From the Division of Cardiovascular Diseases, Cardiovascular Research Institute, and
the Midwest Stem Cell Therapy Center, University of Kansas Medical Center, Kansas
City (M.R.A., A.S., Z.I.S., B.D.); Heart and Vascular Specialists of Oklahoma, Oklahoma
City (V.J.); Division of Cardiology, University of Kentucky, Lexington (A.A.-L.);
and Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology,
Jagiellonian University, Krakow, Poland (E.K.Z.-S). bdawn@kumc.edu.